Sally Bridget Lawlor
Chief Financial Officer · Quoin Pharmaceuticals, Ltd.
- 2025
- Sep 2, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sally Bridget Lawlor files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dennis Langer - $129K in QNRX purchases and sales in the last 12 months
- Michael Myers - $100K in QNRX purchases and sales in the last 12 months
- Denise P. Carter - $100K in QNRX purchases and sales in the last 12 months
- Anthony James Culverwell - $30K in QNRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sally Bridget Lawlor?
Sally Bridget Lawlor is a corporate insider, tracked as Chief Financial Officer of Quoin Pharmaceuticals, Ltd. (QNRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sally Bridget Lawlor submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sally Bridget Lawlor been buying or selling stock?
Recorded transactions: 2 open-market purchases ($50K) and 0 open-market sales across all tracked filings.
